Coherus Stock Drops: CCO Resignation Shakes Market

viernes, 6 de junio de 2025, 5:34 pm ET1 min de lectura
CHRS--
Coherus Oncology, Inc. declined 1.20% in after-hours trading. The company recently announced several board changes, including the resignation of Paul Reider as Chief Commercial Officer and Kimberly J. Tzoumakas from the Board of Directors. Additionally, the company appointed Rita Karachun and Georgia Erbez to its Board of Directors. These changes may have contributed to the stock's decline as investors react to the leadership transitions.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios